Clinical Trials Logo

Nutrition Disorders clinical trials

View clinical trials related to Nutrition Disorders.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04247269 Withdrawn - Clinical trials for Enteral Feeding Intolerance

Review of Enteral Formulas in Children

Start date: August 21, 2020
Phase:
Study type: Observational

Retrospective review of nutrition enteral formula data documented in medical records.

NCT ID: NCT04196517 Withdrawn - Nutrition Disorders Clinical Trials

PALS for Nutrition Education

Start date: February 12, 2020
Phase: N/A
Study type: Interventional

The overall goal of this inquiry is to determine whether PALS is more effective than comparable online resources at educating patients in the outpatient clinic setting about nutrition. Participants will be randomly assigned to view either a PALS article or WebMD article on the same nutrition topic. Participants will then fill out a post-survey to assess knowledge uptake and attitudes regarding healthy eating.

NCT ID: NCT04012333 Withdrawn - Critical Illness Clinical Trials

The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial

EFFORTcombo
Start date: June 2020
Phase: Phase 3
Study type: Interventional

The primary research question: In critically ill patients with nutrition 'risk factors', what is the effect of providing combined EN/PN to the group prescribed a higher dose (≥2.2 grams/kg/day) of protein/amino acid administration compared to a low group prescribed ≤1.2 gram/kg/day (EN only) on patient's functional recovery as measured by 6-minute walk distance just prior to hospital discharge? The hypothesis: Compared to a control group reflective of usual care prescribing practices and an EN only approach, the administration of a higher dose protein/amino acids using EN and PN to nutritionally high-risk critically ill patients will be associated with improved functional outcome.

NCT ID: NCT01946841 Withdrawn - Quality of Life Clinical Trials

Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life

AL-EN-PHED
Start date: August 2013
Phase: Phase 2
Study type: Interventional

The objective of this unblinded study is to assess the nutritional effects of a 12 weeks administration of the specific enteral nutrition (SEN) RealDiet®Renal pockets, as well as the impact on the patients' quality of life.

NCT ID: NCT01569633 Withdrawn - Infant,Premature Clinical Trials

Use of Prokinetics in Early Enteral Feeding in Preterm Infants

Start date: October 2011
Phase: N/A
Study type: Interventional

Objective of this study are: 1) To determine if medication help extreme preterm infants to tolerate feeding better by reaching full feeding earlier.2) Out of two medication; which one is better for efficacy 1) Erythromycin 2) Metoclopramide. Infants who meet inclusion criteria would be entered to study after parental consent. Infant would be blinded to care givers. Infants will be randomized to receive one of three medication for 7-14 days. If infants fail on one medication they will be allowed to crossover to other medication. Infant would be allowed to treat like other infants. Blindness can be broken if deem necessary by attending neonatologist.

NCT ID: NCT01401426 Withdrawn - Obesity Clinical Trials

Randomized Prospective Trial: Single Port Laparoscopic Vertical Sleeve Gastrectomy Versus Conventional Five Port Laparoscopic Vertical Sleeve Gastrectomy Surgery

Start date: July 2010
Phase: N/A
Study type: Interventional

Vertical Sleeve Gastrectomy has been shown to significantly reduce weight and has been approved as a treatment of morbid obesity. The standard laparoscopic operation requires five small incisions for the introduction of instruments and the band into the patient's abdomen. The investigators have developed a technique for performing this operation through a single incision at the belly button. This study compares this method to the conventional 5-incision approach.

NCT ID: NCT00728455 Withdrawn - Obesity Clinical Trials

Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers

Start date: July 2008
Phase: Phase 1
Study type: Interventional

This trial will be conducted in the United States of America (USA). The aim of this clinical trial is to investigate whether NNC 0070-0002-0349 is safe and well tolerated. Groups of eight subjects will be administered subcutaneous injections of NNC 0070-0002-0349 or placebo on Day 1 beginning with a low dose; after which laboratory and vital sign data as well as subject reported adverse events will be evaluated. If safe to proceed, the next group of subjects will be given a higher dose and the safety evaluation performed again before proceeding. In total, 5 dose levels will be evaluated. Subjects will be administered a dose and remain in the clinic until the morning of Day 8 after dosing and vital signs and safety labs as well as blood drawn for pharmacokinetic samples taken. Subjects will return to the clinic on Days 10, 12, 14, 16, 18 and 22 for repeat blood draws and safety labs. Day 22 is the final study visit.